Literature DB >> 33326047

Comparative Study on the Outcome of Periorbital Wrinkles Treated with Laser-Assisted Delivery of Vitamin C or Vitamin C Plus Growth Factors: A Randomized, Double-blind, Clinical Trial.

Barbara Helena Barcaro Machado1, James Frame2, Jufen Zhang2, Mohammad Najlah3.   

Abstract

BACKGROUND: Despite promising results, laser-assisted drug delivery (LADD) is not yet considered as standard therapies and published data rely mainly on laboratory tests, animal experiments or cadaver skin.
OBJECTIVES: This double-blind, prospective, randomized clinical trial investigates the impact in topical application of vitamin C and a cosmeceutical containing growth factors (GFs) on periorbital wrinkles primarily treated with laser skin resurfacing.
MATERIAL AND METHODS: In total, 149 female patients with periorbital wrinkles were consented and randomized into two study groups, R-C (receiving vitamin C only) and R-CGF (receiving vitamin C and a cosmeceutical containing growth factors). The statistical analysis evaluated the efficacy of each treatment regimen using software readouts provided by a three-dimensional stereophotogrammetry system prior to treatment and three months after the procedure. Results were compared to confirm if there was a significant change in the skin roughness and the average depth of the wrinkles between the two groups after treatment.
RESULTS: There was a significant reduction in both skin roughness and average depth of the wrinkles in the group treated with vitamin C and growth factors (p <0.01) than those treated with LADD followed by topical application of vitamin C alone. There were no cutaneous reactions or adverse systemic reactions observed in this study related to LADD with vitamin C and GFs.
CONCLUSION: Controlled laser application might have a great potential to facilitate the absorption of exogenous macromolecules by the skin. Periorbital wrinkles were reduced in both groups, but LADD using vitamin C and GFs provided significantly better results. LEVEL OF EVIDENCE II: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Entities:  

Keywords:  Growth factors; Laser-assisted drug delivery; Laser-assisted medication; Vitamin C; Wrinkles

Year:  2020        PMID: 33326047     DOI: 10.1007/s00266-020-02035-z

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  4 in total

1.  Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.

Authors:  R J Laham; M Rezaee; M Post; F W Sellke; R A Braeckman; D Hung; M Simons
Journal:  Drug Metab Dispos       Date:  1999-07       Impact factor: 3.922

2.  Comparison between topical recombinant human epidermal growth factor and Aloe vera gel in combination with ablative fractional carbon dioxide laser as treatment for striae alba: A randomized double-blind trial.

Authors:  Wareeporn Disphanurat; Arisa Kaewkes; Worapop Suthiwartnarueput
Journal:  Lasers Surg Med       Date:  2019-01-06       Impact factor: 4.025

3.  Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l-ascorbic acid.

Authors:  Michelle Ehrlich; Jaggi Rao; Anju Pabby; Mitchel P Goldman
Journal:  Dermatol Surg       Date:  2006-05       Impact factor: 3.398

Review 4.  Laser assisted drug delivery: a review of an evolving technology.

Authors:  Lindsay R Sklar; Christopher T Burnett; Jill S Waibel; Ronald L Moy; David M Ozog
Journal:  Lasers Surg Med       Date:  2014-03-24       Impact factor: 4.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.